AMAG AMAG Pharmaceuticals Inc

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that its third quarter 2016 financial results will be released on Thursday, November 3, 2016 before the U.S. financial markets open. At 8:00 a.m. ET, management will host a conference call and webcast to discuss the results and provide an update on recent corporate developments.

Dial-in NumberU.S./Canada Dial-in Number: (877) 412-6083International Dial-in Number: (702) 495-1202Conference ID: 96588865

Replay Dial-in Number: (855) 859-2056Replay International Dial-in Number: (404) 537-3406Conference ID: 96588865

A telephone replay will be available from approximately 11:00 a.m. ET on November 3, 2016 through midnight on November 10, 2016.

The webcast with slides will be accessible through the Investors section of the company’s website at www.amagpharma.com. A replay of the webcast will be archived on the website for 30 days.

About AMAGAMAG is a biopharmaceutical company focused on developing and delivering important therapeutics, conducting clinical research in areas of unmet need and creating education and support programs for the patients and families we serve. Our products support the health of patients in the areas of maternal health, anemia management and cancer supportive care. Through CBR®, we also help families to preserve newborn stem cells, which are used today in transplant medicine for certain cancers and blood, immune and metabolic disorders, and have the potential to play a valuable role in the ongoing development of regenerative medicine. For additional company information, please visit www.amagpharma.com.

AMAG Pharmaceuticals® is a registered trademark of AMAG Pharmaceuticals, Inc. CBR® is a registered trademark of CBR Systems, Inc.

AMAG Pharmaceuticals Contact: 
Christi Waarich
Associate Director, Investor Relations
617-498-7638